source
- Lilly's mid‑stage weight‑loss trial looms as amylin design becomes a key differentiatorThe pharmaceutical community is watching a growing debate over how best to design amylin‑based medicines. Analysts say that the structural choices made by companies could determine which candidates…
- Anthropic’s Claude AI designs miniproteins from scratch in new studyAnthropic announced that its AI system Claude was used to design and generate miniproteins from scratch in a recent research campaign. The study showed Claude could propose novel protein sequences…